Echo IQ Limited provides artificial intelligence diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom. The company also EchoSolvTM, a software for identification Aortic Stenosis heart condition. It primarily serves physicians and health systems. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Sydney, Australia.
Stock data | 2023 | Change |
---|---|---|
Price | $0.10193264290956536 | N/A |
Market Cap | $45.71M | N/A |
Shares Outstanding | 448.47M | 14.16% |
Employees | 0 | N/A |
Shareholder Equity | 7.44M | -7.29% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -5.86 | N/A |
P/S Ratio | 626.75 | N/A |
P/B Ratio | 6.15 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.7180 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $72.94K | N/A |
Earnings | -$5.34M | N/A |
EPS | -0.0174 | N/A |
Earnings Yield | -0.1707 | N/A |
Gross Margin | 1.00 | N/A |
Operating Margin | -71.51 | N/A |
Net income margin | -73.19 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $7.06M | N/A |
Cash on Hand | $2.23M | N/A |
Debt to Equity | 0.2695 | 43.78% |
Current Ratio | $1.35 | -7.35% |